Peptide vaccination directed against IDO1-expressing immune cells elicits CD8<sup>+</sup> and CD4<sup>+</sup> T-cell-mediated antitumor immunity and enhanced anti-PD1 responses

Souvik Dey(Indiana University School of Medicine), Alexander J. Muller(Lankenau Institute for Medical Research)
Journal for ImmunoTherapy of Cancer
July 1, 2020
Cited by 48


Related Papers